Source:http://linkedlifedata.com/resource/pubmed/id/16394513
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-1-5
|
pubmed:abstractText |
We previously reported that ten phenylethanoid glycosides including acteoside isolated from the leaves and twigs of Callicarpa dichotoma significantly attenuated glutamate-induced neurotoxicity. In the present study, we examined anti-amnesic activity of acteoside using scopolamine-induced (1 mg/kg body weight, s.c.) amnesic mice with both passive avoidance and Morris water maze tests. Acute oral treatment (single administration prior to scopolamine treatment) of mice with acteoside (1.0, 2.5 mg/kg body weight) significantly mitigated scopolamine-induced memory deficits in the passive avoidance test. It is interesting to note that prolonged oral daily treatment of mice with much lower amount (0.1 mg/kg body weight) of acteoside for 10 d reversed the scopolamine-induced memory deficits. In the Morris water maze, prolonged oral treatment with acteoside (prolonged daily administration of 1.0 mg/kg body weight for 10 d) significantly ameliorated scopolamine-induced memory deficits showing the formation of long-term and/or short-term spatial memory. We suggest, therefore, that acteoside has anti-amnesic activity that may ultimately hold significant therapeutic value in alleviating certain memory impairment observed in Alzheimer's disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Glucosides,
http://linkedlifedata.com/resource/pubmed/chemical/Muscarinic Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Phenols,
http://linkedlifedata.com/resource/pubmed/chemical/Scopolamine Hydrobromide,
http://linkedlifedata.com/resource/pubmed/chemical/acteoside
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0918-6158
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
71-4
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16394513-Animals,
pubmed-meshheading:16394513-Avoidance Learning,
pubmed-meshheading:16394513-Callicarpa,
pubmed-meshheading:16394513-Cognition,
pubmed-meshheading:16394513-Glucosides,
pubmed-meshheading:16394513-Male,
pubmed-meshheading:16394513-Maze Learning,
pubmed-meshheading:16394513-Memory Disorders,
pubmed-meshheading:16394513-Mice,
pubmed-meshheading:16394513-Mice, Inbred ICR,
pubmed-meshheading:16394513-Muscarinic Antagonists,
pubmed-meshheading:16394513-Phenols,
pubmed-meshheading:16394513-Scopolamine Hydrobromide
|
pubmed:year |
2006
|
pubmed:articleTitle |
Acteoside of Callicarpa dichotoma attenuates scopolamine-induced memory impairments.
|
pubmed:affiliation |
College of Pharmacy and Research Institute of Pharmaceutical Science, Seoul National University, Kore, Seoul, Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|